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Increased levels of Fibrogen growth factor 21 (FGF21) is an emerging risk marker for cardiometabolic (CM) disease(1). Little detail is
known about the impact of the human diet on FGF21 levels. The aim of this investigation was to assess potential associations between
mean daily dietary macronutrient intake and FGF21 levels in a sample of 10 healthy normal-weight and overweight Caucasian adults
aged 32–60 (80 % male) at increased CM risk(2). This pilot study received ethical approval from Liverpool John Moores University
Research Ethics Committee (16/ELS/029) and was registered with ClinicalTrials.gov (Ref. NCT03257085).
Participants were randomly allocated to one of two groups and asked to either consume <50 g/d of dietary CHO (low-carb (LC)) or
to follow the UK dietary guidelines and obtain >50 % energy from CHO for a duration of 8 weeks. Blood plasma samples were col-
lected at baseline (BL), interim point (IP) and endpoint (EP) after a 12-hour overnight fast, immediately processed and frozen at −80°C.
Thawed plasma samples were analysed via Quantikine® enzyme-linked immunosorbent assay (ELISA) (R&D Systems) for FGF21
levels. Two-way mixed ANOVA and Pearson’s partial correlation adjusted for estimated weekly moderate and vigorous activity
was undertaken using IBM SPSS 24®.
There were no effects for diet between groups or over time (data not shown). Signiﬁcant correlations between macronutrient intakes
and FGF21 levels were found for both groups at IP, but not at BL or EP. Moderate and signiﬁcant positive correlations were found in
the overall group for intake (g/d) for glucose (rpartial = ·699, p = ·04) and fructose (rpartial = ·686, p = ·04) and strong and signiﬁcant
positive correlations for non-milk extrinsic sugars (rpartial = ·742, p = ·02). Strong and signiﬁcant positive correlations were also
found in the LC group for glucose intake (g/d) (rpartial = ·980, p = ·02) and fructose (rpartial = ·967, p = ·03) and for protein (rpartial
= ·998, p = ·002) after adjusting for physical activity. Mean carbohydrate intake (g/d) was 160·0 (s.d. 124·5) overall and 44·2
(s.d. 14·9) in the LC group at IP. Mean protein intake (g/d) was 113·2 (21·4) 130·0 (s.d. 15·9) overall and in the LC group at IP.
Mean FGF21 levels were 179·9 pg/mL (s.d. 144·9) in the overall group and 94.4 pg/ML (s.d. 48.6) in the LC group at IP.
In conclusion, low-carbohydrate diets provide the opportunity to assess responses to even small amounts of CHO, which are likely
to be replaced in part by proteins. Despite low overall intakes of fructose and glucose in the LC group, strong and positive correlations
with FGF21 levels were observed. The lower levels of FGF21 in the LC compared to the overall group are in line with ﬁndings that
FGF21 levels are elevated with high-carbohydrate, low-protein diets with dietary fats having only minor impact(3). However, the
majority of studies have still been undertaken using rodent models. The impact of dietary macronutrients on FGF21 levels as
novel CMR marker in humans and the mechanism behind this relationship warrant further investigation.
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Total %TE Intake (g/d)
kcal CHO NMES PROT FAT CHO GLU FRU NMES PROT FAT
r r r r r r r r r r r
T −·214 ·623 ·635 −·326 −·491 ·448 ·699* ·686* ·742* −·606 −·496
LC ·143 ·637 ·937 ·427 −·059 ·722 ·980* ·967* ·919 ·998** −·080
CHO-Total carbohydrates, FAT-Total fat, FRU-Fructose, GLUC-Glucose, LC-low-carbohydrate, high-fat group, NMES-non-milk extrinsic sugars, PROT-protein,
T – total, %TE – percentage total energy, *p < ·05 **p < ·005.
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